These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 17658996)
1. Narrowband UVB therapy for vitiligo: does the repigmentation last? Sitek JC; Loeb M; Ronnevig JR J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996 [TBL] [Abstract][Full Text] [Related]
2. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study. Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006 [TBL] [Abstract][Full Text] [Related]
3. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156 [TBL] [Abstract][Full Text] [Related]
4. Treatment of vitiligo with broadband ultraviolet B and vitamins. Don P; Iuga A; Dacko A; Hardick K Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381 [TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Yones SS; Palmer RA; Garibaldinos TM; Hawk JL Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217 [TBL] [Abstract][Full Text] [Related]
6. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Kullavanijaya P; Lim HW Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875 [TBL] [Abstract][Full Text] [Related]
7. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Kanwar AJ; Dogra S; Parsad D; Kumar B Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664 [TBL] [Abstract][Full Text] [Related]
8. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369 [TBL] [Abstract][Full Text] [Related]
9. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843 [TBL] [Abstract][Full Text] [Related]
10. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004 [TBL] [Abstract][Full Text] [Related]
11. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. Bhatnagar A; Kanwar AJ; Parsad D; De D J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845 [TBL] [Abstract][Full Text] [Related]
12. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Asawanonda P; Klahan SO Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233 [TBL] [Abstract][Full Text] [Related]
13. Narrow-band UVB for the treatment of generalized vitiligo in children. Kanwar AJ; Dogra S Clin Exp Dermatol; 2005 Jul; 30(4):332-6. PubMed ID: 15953060 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391 [TBL] [Abstract][Full Text] [Related]
15. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562 [TBL] [Abstract][Full Text] [Related]
16. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631 [TBL] [Abstract][Full Text] [Related]
17. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients. Percivalle S; Piccino R; Caccialanza M; Forti S G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735 [TBL] [Abstract][Full Text] [Related]
19. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. Fai D; Cassano N; Vena GA J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000 [TBL] [Abstract][Full Text] [Related]
20. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]